These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1495743)

  • 21. [Calcitonin].
    Nakano T
    Clin Calcium; 2008 Oct; 18(10):1460-8. PubMed ID: 18830043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A years' treatment of Paget's disease of bone using salmon calcitonin via nasal spray].
    Denis D; Lecart MP; Deroisy R; Jeugmans-Huynen AM; Albert A; Reginster JY; Franchimont P
    Rev Med Liege; 1989 Jan; 44(1):23-7. PubMed ID: 2916086
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
    Binkley N; Bolognese M; Sidorowicz-Bialynicka A; Vally T; Trout R; Miller C; Buben CE; Gilligan JP; Krause DS;
    J Bone Miner Res; 2012 Aug; 27(8):1821-9. PubMed ID: 22437792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between onset of pain relief and patient satisfaction with fentanyl pectin nasal spray for breakthrough pain in cancer.
    Torres LM; Revnic J; Knight AD; Perelman M
    J Palliat Med; 2014 Oct; 17(10):1150-7. PubMed ID: 25211772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Calcitonin Salmon Nasal Spray: similarity of peptide formulated in chlorobutanol compared to benzalkonium chloride as preservative.
    Costantino HR; Culley H; Chen L; Morris D; Houston M; Roth S; Phoenix MJ; Foerder C; Philo JS; Arakawa T; Eidenschink L; Andersen NH; Brandt G; Quay SC
    J Pharm Sci; 2009 Oct; 98(10):3691-706. PubMed ID: 19226627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal fentanyl versus fentanyl pectin nasal spray for the management of breakthrough cancer pain in doses proportional to basal opioid regimen.
    Mercadante S; Prestia G; Adile C; Casuccio A
    J Pain; 2014 Jun; 15(6):602-7. PubMed ID: 24561001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal administration of glucagon and human calcitonin to healthy subjects: a comparison of powders and spray solutions and of different enhancing agents.
    Pontiroli AE; Alberetto M; Calderara A; Pajetta E; Pozza G
    Eur J Clin Pharmacol; 1989; 37(4):427-30. PubMed ID: 2598979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of massage on pain intensity, analgesics and quality of life in patients with cancer pain: a pilot study of a randomized clinical trial conducted within hospice care delivery.
    Wilkie DJ; Kampbell J; Cutshall S; Halabisky H; Harmon H; Johnson LP; Weinacht L; Rake-Marona M
    Hosp J; 2000; 15(3):31-53. PubMed ID: 11315685
    [No Abstract]   [Full Text] [Related]  

  • 29. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
    Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
    Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects.
    Reginster JY; Denis D; Albert A; Franchimont P
    Bone Miner; 1987 Apr; 2(2):133-40. PubMed ID: 3504725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intranasal salmon calcitonin for the prophylaxis of bone mineral loss in steroid-treated chronic obstructive lung diseases ].
    Böhning W; Ringe JD; Welzel D; Bode V
    Arzneimittelforschung; 1990 Sep; 40(9):1000-3. PubMed ID: 2080934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcitonin nasal spray in patients with chronic asthma: a double-blind crossover study vs placebo.
    Dal Negro R; Turco P; Pomari C; Trevisan F
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):144-6. PubMed ID: 2071263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New modes of administration of salmon calcitonin in Paget's disease. Nasal spray and suppository.
    Nagant de Deuxchaisnes C; Devogelaer JP; Huaux JP; Dufour JP; Esselinckx W; Engelbeen JP; Stasse P; Hermans P; de Buisseret JP
    Clin Orthop Relat Res; 1987 Apr; (217):56-71. PubMed ID: 3549096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
    Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fentanyl nasal spray for the treatment of cancer pain.
    Mystakidou K; Panagiotou I; Gouliamos A
    Expert Opin Pharmacother; 2011 Jul; 12(10):1653-9. PubMed ID: 21609189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal calcitonin.
    Silverman SL
    Endocrine; 1997 Apr; 6(2):199-202. PubMed ID: 9225136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of ovariectomized patients with intramuscular and nasal-spray synthetic calcitonin].
    Zara C; Perotti F; Ferraro R; Lauri A; Saviotti C; Montrasio MG; Caprotti M; Polatti F
    Minerva Endocrinol; 1989; 14(1):53-6. PubMed ID: 2733647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.
    Pun KK; Chan LW
    Clin Ther; 1989; 11(2):205-9. PubMed ID: 2660996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analgetic activity of calcitonin in patients with painful osteolytic metastases of breast cancer. Results of a controlled randomized study.
    Roth A; Kolarić K
    Oncology; 1986; 43(5):283-7. PubMed ID: 3531953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.